Concepedia

Huifang Kong

HK

Statistics

Publications

7

Citations

228

H-Index

7

Active since

2017

Affiliations

Chinese PLA General Hospital(Current)

Peking University

Beijing Shijitan Hospital

Affiliated Hospital of Guizhou Medical University

Guiyang Medical University

Huifang Kong is an author at Chinese PLA General Hospital specializing in oncology, molecular oncology, and liver cancer.

Publications per year

2017–2022

7

Publications

7

MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents

Bin Yang, Chunping Wang, Hui Xie et al. · Cell Death and Disease · 2019 · 81 citations · Full text

, , +11

Reactivity toward Bifidobacterium longum and Enterococcus hirae demonstrate robust CD8+ T cell response and better prognosis in HBV-related hepatocellular carcinoma

Yihui Rong, Zheng Dong, Zhixian Hong et al. · Experimental Cell Research · 2017 · 57 citations

, , +16

Long intergenic non-protein coding RNA 1273 confers sorafenib resistance in hepatocellular carcinoma via regulation of methyltransferase 3

Huifang Kong, Jie Sun, Wei Zhang et al. · Bioengineered · 2022 · 37 citations · Full text

, , +17

Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma

Wei Zhang, Huifang Kong, Xudong Gao et al. · World Journal of Gastroenterology · 2020 · 17 citations · Full text

, , +17

Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker

Yan Chen, Xuemei Ma, Xuefeng Zhang et al. · Hepatology International · 2022 · 14 citations

, , +15

1–5 of 7